Evidence map›Paper›PMID 35603609›Full record

ReviewTissue barriers2023

The diet-microbiota axis: a key regulator of intestinal permeability in human health and disease.

Raju Lama Tamang, Anthony F Juritsch, Rizwan Ahmad, Jeffrey D Salomon, Punita Dhawan, Amanda E Ramer-Tait, Amar B Singh

Open access · greenAbstract readReview
In one paragraph

Review in Tissue barriers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Therapeutic potential ofFrontiers in veterinary science · 2025
    Article
  9. Article
  10. Article
  11. Nutrients · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Raju Lama TamangDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, USA.ORCID 0000-0002-3177-563X
Anthony F JuritschDepartment of Food Science and Technology, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.ORCID 0000-0001-6277-283X
Rizwan AhmadDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, USA.ORCID 0000-0003-0331-6687
Jeffrey D SalomonDepartment of Pediatrics, University of Nebraska Medical Center, Omaha, NE, USA.ORCID 0000-0001-6893-2937
Punita DhawanDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, USA.ORCID 0000-0003-3434-8155
Amanda E Ramer-TaitDepartment of Food Science and Technology, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.ORCID 0000-0003-0950-7548
Amar B SinghDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, USA.ORCID 0000-0003-1908-8594
University of Nebraska Medical Center · USUniversity of Nebraska–Lincoln · USVA Nebraska Western Iowa Health Care System · US

Funding

Impact of CLDN1 inhibition on chemoresistance and metastasis of colon cancerR01CA250383 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Punita Dhawan · 2021 to 2026
$3.0M
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel diseaseR01DK124095 · NIDDK · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI OUPICKY, DAVID, SINGH, AMAR B · 2020 to 2023
$2.1M
Role of Claudin-2 in Colon TumorigenesisI01BX002761 · VA · OMAHA VA MEDICAL CENTER · PI SINGH, AMAR B · 2016 to 2023
–
BLRD VA I01 BX002086BLRD VA I01 BX002761BLRD VA IK6 BX006481NCI NIH HHS R01 CA250383NIDDK NIH HHS R01 DK124095
6 · The paper itself

Abstract

The intestinal barrier orchestrates selective permeability to nutrients and metabolites while excluding noxious stimuli. Recent scientific advances establishing a causal role for the gut microbiota in human health outcomes have generated a resurgent interest toward intestinal permeability. Considering the well-established role of the gut barrier in protection against foreign antigens, there is mounting evidence for a causal link between gut permeability and the microbiome in regulating human health. However, an understanding of the dynamic host-microbiota interactions that govern intestinal barrier functions remains poorly defined. Furthermore, the system-level mechanisms by which microbiome-targeted therapies, such as probiotics and prebiotics, simultaneously promote intestinal barrier function and host health remain an area of active investigation. This review summarizes the recent advances in understanding the dynamics of intestinal permeability in human health and its integration with gut microbiota. We further summarize mechanisms by which probiotics/prebiotics influence the gut microbiota and intestinal barrier functions.

Indexed as

MicrobiotaProbioticsDietHumansPermeabilityPrebioticsPrebioticsdietGut barriergut permeabilitymicrobiotaProbiotics

Identifiers

PMID35603609
PMCPMC10161950
OpenAlexW4281255065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.